Baseline IGF-1 and Stimulated GH Can Predict Pediatric GHD Severity, Response to Treatment

November 3, 2021

Baseline insulin-like growth factor-1 (IGF-1) and stimulated peak growth hormone response can serve as predictors for how severe growth hormone deficiency is in pediatric patients as well as how these patients will respond to different treatments, according to a study recently published in the Journal of the Endocrine Society. Researchers led by Michael O. Thorner, […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

Growth Issues Pediatric Health

←Insulin at 100: How Far We’ve Come and the Work Still to Be Done

Insulin Resistance: New Insights into Development, Diagnosis, and Treatment→

View Archives

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today